Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma (Q38942795)

7 September 2017

Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma (English)

1 reference

7 September 2017

1 reference

Dong Zhao

1

1 reference

7 September 2017

Xi-Dai Long

2

1 reference

7 September 2017

Tian-Fei Lu

3

1 reference

7 September 2017

Tao Wang

4

1 reference

7 September 2017

Wei-Wei Zhang

5

1 reference

7 September 2017

Yi-Xiao Liu

6

1 reference

7 September 2017

Xiao-Lan Cui

7

1 reference

7 September 2017

Hui-Juan Dai

8

1 reference

7 September 2017

Feng Xue

9

1 reference

7 September 2017

Qiang Xia

10

1 reference

7 September 2017

language of work or name

English

0 references

publication date

21 November 2014

1 reference

International Journal of Cancer

7 September 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 September 2017

136

1 reference

7 September 2017

11

1 reference

7 September 2017

2556-2565

1 reference

Global cancer statistics, 2002

7 September 2017

1 reference

Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes

21 January 2018

1 reference

Long-term metformin use is associated with decreased risk of breast cancer.

21 January 2018

1 reference

Antidiabetic therapies affect risk of pancreatic cancer

21 January 2018

1 reference

Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells

21 January 2018

1 reference

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk

21 January 2018

1 reference

Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.

21 January 2018

1 reference

Metformin: a therapeutic opportunity in breast cancer

21 January 2018

1 reference

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

21 January 2018

1 reference

Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients

21 January 2018

1 reference

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

21 January 2018

1 reference

Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9.

21 January 2018

1 reference

Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators

21 January 2018

1 reference

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression

21 January 2018

1 reference

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma

21 January 2018

1 reference

Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma

21 January 2018

1 reference

Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma

21 January 2018

1 reference

Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking

21 January 2018

1 reference

Cutting edge: immune cells as sources and targets of the IL-10 family members?

21 January 2018

1 reference

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

21 January 2018

1 reference

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma

21 January 2018

1 reference

Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.

21 January 2018

1 reference

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.

21 January 2018

1 reference

Prevention of pancreatic cancer induction in hamsters by metformin

21 January 2018

1 reference

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

21 January 2018

1 reference

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

21 January 2018

1 reference

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

21 January 2018

1 reference

Recent advances in IL-22 biology.

21 January 2018

1 reference

Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation

21 January 2018

1 reference

IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection

21 January 2018

1 reference

A novel role for IL-22R1 as a driver of inflammation

21 January 2018

1 reference

Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R

21 January 2018

1 reference

Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes

21 January 2018

1 reference

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

21 January 2018

1 reference

15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29305

1 reference

7 September 2017

1 reference